CCR2 and neoplasm: CCL20 induce the recruitment of Vα24-invariant NKT cells to the hypoxic TME, where the antitumor function and viability of NKT cells were repressed.76 TAMs produce CCL2 which induce CCR2+ monocytic MDSCs migration from bone marrow to tumor.